Veracyte
VCYT
25.13
+0.09
+0.36%
Veracyte
US · VCYT
#2330 by market cap
Listed 1970
25.13
+0.09
+0.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
William Blair Maintains Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $66Market Newswire · 2026/7/31
-
Stephens Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $40Market Newswire · 2026/11/11
-
UBS Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/9/9
-
Rating change
Jefferies Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $70Market Newswire · 2026/7/9
-
Rating change
Piper Sandler Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $66Market Newswire · 2026/7/15
-
Rating change
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Raises Target Price to $60Market Newswire · 2026/7/14
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $69Market Newswire · 2026/7/31
-
Rating change
William Blair Initiates Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/7/31
-
Rating change
CCORF Maintains Veracyte(VCYT.US) With Hold Rating, Cuts Target Price to $50Market Newswire · 2026/8/3
-
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54Market Newswire · 2026/11/5
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $69Market Newswire · 2026/9/15
-
Rating change
Craig-Hallum Maintains Veracyte(VCYT.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
Freedom Capital Markets Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $66Market Newswire · 2026/9/15
-
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $30Market Newswire · 2026/11/10
-
Rating change
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Cuts Target Price to $44Market Newswire · 2026/8/4
-
Rating change
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $54Market Newswire · 2026/8/4
-
UBS Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $35Market Newswire · 2026/11/9
-
Rating change
Stephens Initiates Veracyte(VCYT.US) With Buy Rating, Announces Target Price $55Market Newswire · 2026/8/4
-
Rating change
Morgan Stanley Maintains Veracyte(VCYT.US) With Sell Rating, Raises Target Price to $47Market Newswire · 2026/7/9
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/5/28
-
Rating change
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/6/29
-
Rating change
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Raises Target Price to $57Market Newswire · 2026/6/1
-
Piper Sandler Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $54Market Newswire · 2026/9/17
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Veracyte discussion 0 comments